Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study
Xiaocong Li Marston, R. Wang, Yu‐Chen Yeh, Lisa Zimmermann, X. Ye, Xīn Gào, Bernd Brüggenjürgen, Martin Unverdorben
Topics & Concepts
EdoxabanMedicineApixabanRivaroxabanDabigatranAtrial fibrillationInternal medicineVitamin K antagonistWarfarinHazard ratioAnesthesiaCardiologyConfidence intervalAtrial Fibrillation Management and OutcomesVitamin K Research StudiesIntracerebral and Subarachnoid Hemorrhage Research